trimetazidine has been researched along with Chronic Disease in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.34) | 18.7374 |
| 1990's | 1 (3.45) | 18.2507 |
| 2000's | 11 (37.93) | 29.6817 |
| 2010's | 10 (34.48) | 24.3611 |
| 2020's | 4 (13.79) | 2.80 |
| Authors | Studies |
|---|---|
| Min, Z; Qiuhong, S; Ran, Z; Xuelu, L; Yong, M | 1 |
| Herold, Z; Nagy, VL | 1 |
| Bohdan, M; Gruchała, M; Moryś, J; Niedoszytko, P; Stopczyńska, I; Wiśniewski, P | 1 |
| Fu, B; Ma, S; Zhang, X | 1 |
| Andrikopoulos, G; Manolis, A; Tsioufis, K | 1 |
| Chen, J; Zhou, X | 1 |
| Osmolovskaya, YF; Tereshchenko, SN; Zhirov, IV | 1 |
| Gorbunova, ML; Vilkova, AV | 1 |
| Arora, R; Jawad, E | 1 |
| Arioli, F; Cera, M; Facchini, A; Fragasso, G; Gardini, C; Godino, C; Margonato, A; Marinosci, G; Montanaro, C; Salerno, A; Spoladore, R | 1 |
| Antony, R; Dargie, HJ | 1 |
| Gao, D; Hao, G; Meng, Z; Ning, N; Niu, X | 1 |
| Ashrafian, H; Neubauer, S | 1 |
| Arioli, F; Bassanelli, G; Calori, G; Cuko, A; Fragasso, G; Lattuada, G; Luzi, L; Margonato, A; Perseghin, G; Ragogna, F; Salerno, A; Scollo, A; Spoladore, R | 1 |
| Ivanova, EP; Morozova, TE; Rykova, SM | 1 |
| Kutuzova, AE; Liasnikova, EA; Mikhaĭlova, IE; Nedoshivin, AO; Nesterova, IV; Novikova, NA; Perepech, NB; Rubashkina, EI | 1 |
| Almazov, VV; Kazarin, VV; Nifontov, EM; Rudomanov, OG; Shlyakhto, EV; Vakhrameyeva, IV; Vakhrameyeva, NV; Zakharov, DV | 1 |
| Fedorova, TA; Il'ina, IuV; Rybakova, MK; Sotnikova, TI | 1 |
| McCullough, PA | 1 |
| Arora, R; Parang, P; Singh, B | 1 |
| Belardinelli, R; Purcaro, A; Solenghi, M; Volpe, L | 1 |
| Iushchuk, EN; Khadzegova, AB; Sadulaeva, IA; Shkol'nik, EL; Vakhromeeva, MN; Vasiuk, IuA; Vit'ko, NK | 1 |
| Chaitman, BR; Sano, J | 1 |
| Demidova, IV; Drozdov, VN; Levchuk, NN; Tereshchenko, SN | 1 |
| Batur, Y; Dinçer, C; Erkuş, M; Girgin, F; Karaoglu, O; Ozütemiz, O; Tanyalçin, T; Tüzün, S | 1 |
| Stanley, WC | 1 |
| Passeron, J | 1 |
| Brochier, M; Demange, J; Deroux, A; Ducloux, G; Monpère, C; Warin, JF | 1 |
| Brochier, M; Demange, J; Ducloux, G; Monpère, C; Warin, JF | 1 |
10 review(s) available for trimetazidine and Chronic Disease
| Article | Year |
|---|---|
Clinical effect of various trimetazidine formulations in chronic coronary syndrome
Topics: Angina, Stable; Chronic Disease; Coronary Disease; Humans; Randomized Controlled Trials as Topic; Treatment Outcome; Trimetazidine | 2020 |
Trimetazidine and cardioprotection: facts and perspectives.
Topics: Angina, Stable; Cardiotonic Agents; Chronic Disease; Heart Failure; Humans; Patient Selection; Practice Guidelines as Topic; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2015 |
Is treatment with trimetazidine beneficial in patients with chronic heart failure?
Topics: C-Reactive Protein; Chronic Disease; Female; Heart Failure; Humans; Male; Natriuretic Peptide, Brain; PubMed; Randomized Controlled Trials as Topic; Stroke Volume; Trimetazidine; Vasodilator Agents | 2014 |
[Trimetazidine in the Treatment of Chronic HeartFailure].
Topics: Chronic Disease; Heart Failure; Humans; Trimetazidine; Vasodilator Agents | 2016 |
Chronic stable angina pectoris.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetanilides; Angina Pectoris; Antihypertensive Agents; Benzazepines; Bosentan; Chronic Disease; Counterpulsation; Cyclic Nucleotide-Gated Cation Channels; Exercise Test; Heart Murmurs; Humans; Ivabradine; Myocardial Contraction; Myocardial Ischemia; Myocardial Revascularization; Myocardium; Nicorandil; Oxygen Consumption; Perhexiline; Piperazines; Protein Kinase Inhibitors; Ranolazine; Sulfonamides; Trimetazidine; Vasodilator Agents | 2008 |
Trimetazidine: a meta-analysis of randomised controlled trials in heart failure.
Topics: Acetyl-CoA C-Acyltransferase; Adult; Chronic Disease; Enzyme Inhibitors; Exercise Tolerance; Heart Failure; Humans; Randomized Controlled Trials as Topic; Stroke Volume; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Remodeling | 2011 |
Chronic angina: new medical options for treatment.
Topics: Acetanilides; Angina Pectoris; Cardiovascular Agents; Chronic Disease; Enzyme Inhibitors; Humans; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 2005 |
Metabolic modulators for chronic cardiac ischemia.
Topics: Acetanilides; Animals; Carnitine; Chronic Disease; Drug Evaluation, Preclinical; Enzyme Inhibitors; Heart; Humans; Lipid Metabolism; Myocardial Ischemia; Myocardium; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Trimetazidine; Vasodilator Agents; Vitamin B Complex | 2005 |
Novel therapeutic approaches to treating chronic angina in the setting of chronic ischemic heart disease.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Chronic Disease; Enzyme Inhibitors; Humans; Ivabradine; Myocardial Ischemia; Nicorandil; Nitro Compounds; Piperazines; Ranolazine; rho-Associated Kinases; Sinoatrial Node; Trimetazidine; Vasodilator Agents | 2007 |
Partial fatty acid oxidation inhibitors for stable angina.
Topics: Acetanilides; Adenosine Triphosphate; Angina Pectoris; Chronic Disease; Energy Metabolism; Fatty Acids; Humans; Myocardium; Oxidation-Reduction; Oxygen Consumption; Piperazines; Ranolazine; Trimetazidine | 2002 |
11 trial(s) available for trimetazidine and Chronic Disease
| Article | Year |
|---|---|
Effects of trimetazidine in patients with severe chronic heart failure with reduced left ventricular ejection fraction: A prospective, randomized, open-label, cross-over study.
Topics: Aged; Chronic Disease; Cross-Over Studies; Heart Failure; Humans; Middle Aged; Prospective Studies; Quality of Life; Stroke Volume; Trimetazidine; Vasodilator Agents; Ventricular Function, Left | 2022 |
Beneficial electrophysiological effects of trimetazidine in patients with postischemic chronic heart failure.
Topics: Aged; Aged, 80 and over; Antisocial Personality Disorder; Arrhythmias, Cardiac; Chronic Disease; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Risk Factors; Trimetazidine; Vasodilator Agents | 2010 |
Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure.
Topics: Aged; Calorimetry; Chronic Disease; Echocardiography; Energy Metabolism; Fatty Acids; Female; Heart Failure; Humans; Male; Oxidation-Reduction; Stroke Volume; Trimetazidine; Vasodilator Agents | 2011 |
[Trimetazidine in correction of chronic heart failure in patients with ischemic heart disease].
Topics: Chronic Disease; Cross-Sectional Studies; Humans; Middle Aged; Myocardial Ischemia; Prospective Studies; Severity of Illness Index; Trimetazidine; Vasodilator Agents | 2002 |
Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Chronic Disease; Drug Therapy, Combination; Electrocardiography; Exercise Test; Humans; Male; Middle Aged; Nitrates; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Function, Left | 2002 |
[Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
Topics: Aged; Aged, 80 and over; Bisoprolol; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Sympathomimetics; Trimetazidine; Vasodilator Agents | 2004 |
Trimetazidine improves endothelial dysfunction in chronic heart failure: an antioxidant effect.
Topics: Antioxidants; Cardiomyopathy, Dilated; Chronic Disease; Endothelium, Vascular; Female; Heart Failure; Humans; Male; Middle Aged; Trimetazidine; Vasodilation; Vasodilator Agents | 2007 |
[Comparative trial of efficacy of trimethasidine MB and 3-(2,2,2-trimethylhydrasine) propionate dihydrate in chronic heart failure].
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Chronic Disease; Combined Modality Therapy; Diuretics; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Methylhydrazines; Middle Aged; Positron-Emission Tomography; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2007 |
[Effectiveness of trimetazidine in stable effort angina due to chronic coronary insufficiency. A double-blind versus placebo study].
Topics: Angina Pectoris; Chronic Disease; Coronary Disease; Double-Blind Method; Exercise Test; Humans; Male; Piperazines; Trimetazidine | 1986 |
[Therapeutic value of a combination of trimetazidine with a calcium inhibitor in the treatment of chronic coronary insufficiency].
Topics: Chronic Disease; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Heart; Humans; Male; Nifedipine; Piperazines; Trimetazidine | 1986 |
[Value of the combination of trimetazidine and a calcium inhibitor in the treatment of chronic coronary insufficiency. Double-blind controlled study versus placebo].
Topics: Calcium Channel Blockers; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Piperazines; Trimetazidine | 1986 |
8 other study(ies) available for trimetazidine and Chronic Disease
| Article | Year |
|---|---|
Effectiveness of Trimetazidine in Patients with Chronic Heart Failure Stratified by the Expression of Soluble Suppression of Tumorigenicity-2 (sST2): A Prospective Cohort Study.
Topics: Biomarkers; Chronic Disease; Heart Failure; Humans; Prospective Studies; Quality of Life; Trimetazidine | 2022 |
Effects of trimetazidine in combination with bisoprolol in patients with chronic heart failure and concomitant chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis.
Topics: Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Chronic Disease; Drug Therapy, Combination; Heart Failure; Humans; Meta-Analysis as Topic; Observational Studies as Topic; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Research Design; Systematic Reviews as Topic; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2021 |
[Assessment of Efficacy and Safety of Metabolic Therapy With Trimetazidine MB in Patients With Ischemic Heart Disease and Chronic Heart Failure].
Topics: Chronic Disease; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Trimetazidine; Vasodilator Agents | 2016 |
Allopurinol for chronic stable angina: old drug, new tricks?
Topics: Allopurinol; Angina Pectoris; Cardiovascular Agents; Chronic Disease; Enzyme Inhibitors; Humans; Trimetazidine; Vasodilator Agents | 2010 |
Metabolic modulation in heart failure: high time for a definitive clinical trial.
Topics: Acetyl-CoA C-Acyltransferase; Chronic Disease; Enzyme Inhibitors; Heart Failure; Humans; Meta-Analysis as Topic; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2011 |
[Clinico-economical aspects of application of trimetazidine MB in patients with chronic heart failure and cardiac rhythm disturbances].
Topics: Aged; Arrhythmias, Cardiac; Chronic Disease; Costs and Cost Analysis; Disease Management; Electrocardiography; Exercise Test; Exercise Tolerance; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Monitoring, Physiologic; Remission Induction; Severity of Illness Index; Trimetazidine; Vasodilator Agents | 2011 |
[Plasma hemostasis and biochemical indices in trimetazidine treatment of patients with chronic heart failure].
Topics: Acid Phosphatase; Adult; Aged; Biomarkers; Blood Coagulation Factors; Cholesterol, HDL; Chronic Disease; Creatinine; Female; Follow-Up Studies; Heart Failure; Hemostasis; Humans; Male; Middle Aged; Plasma; Treatment Outcome; Triglycerides; Trimetazidine; Vasodilator Agents | 1998 |
Effects of trimetazidine on oxidant/antioxidant status in trinitrobenzenesulfonic acid-induced chronic colitis.
Topics: Administration, Rectal; Animals; Chronic Disease; Colitis; Ethanol; Glutathione; Injections, Intraperitoneal; Lipid Peroxidation; Male; Malondialdehyde; Peroxidase; Rats; Rats, Sprague-Dawley; Solvents; Trimetazidine; Trinitrobenzenesulfonic Acid; Vasodilator Agents | 2000 |